Modular Medical, Inc. 10-Q

Item 5. Other Information None. 18 Item 6. Exhibits Exhibit Reference Filed or Furnished Number Exhibit Description Form Exhibit Filing Date Herewith 1.1 Sales Agreement, dated as of November 22, 2023, between Modular Medical, Inc. and Leerink Partners LLC 8-K 11/22/2023 10.1 Modular Medical, Inc. Two-Part FDA Submission and Clearance Milestone Bonus Program 8-K 10/05/2023 31.1 Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 31.2 Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 32.1 Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 101.INS Inline XBRL Instance Document X 101.SCH Inline XBRL Taxonomy Extension Schema Document X 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document X 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document X 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document X 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). X 19 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MODULAR MEDICAL, INC. Date: February 13, 2024 By: /s/ James E. Besser James E. Besser Chief Executive Officer (Principal Executive Officer) By: /s/ Paul DiPerna Paul DiPerna Chairman, President, Chief Financial Officer and Treasurer (Principal Financial Officer) 20